Integrated machine learning constructed a circadian-rhythm-related model to assess clinical outcomes and therapeutic advantages in hepatocellular carcinoma
We proposed a CR-related risk classifier in HCC, to predict patients' overall survival (OS) and therapeutic response. Targeting CR could be a promising treatment modality against HCC.
Authors
- Ziyuan Xu (ORCID: https://orcid.org/0009-0006-5824-3007)
- Xi Zou (ORCID: https://orcid.org/0000-0003-2893-3526)
- Wei Huang (ORCID: https://orcid.org/0000-0002-0274-8923)
- Shenlin Liu (ORCID: https://orcid.org/0000-0001-9959-3704)
Institutions
- Nanjing University of Chinese Medicine (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.21037/tcr-24-1155
- Citations
- 3
- Primary Topic
- Market Dynamics and Volatility
- Type
- article
- Field-Weighted Citation Impact
- 9.39